Insulet Corporation
PODD
149.41−0.62 (−0.41%)Nov 12, 4:36 PM ET
Key stats
- Open
- 150.42
- Day high
- 151.60
- Day low
- 148.80
- Previous close
- 150.03
- Volume
- 745.8K
- VWAP
- 149.89
- 52-week high
- 354.88
- 52-week low
- 126.40
- Market cap
- 10.41B
- Shares out
- 69.37M
- Employees
- 5,400
- Listed
- 2007
About Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · ACTON, MA · insulet.com
Options · expiring Nov 20
Nov 12, 4:00 PM ET- Call open interest
- 4.1K
- Put open interest
- 2.1K
- Put/call
- 0.53
- At-the-money IV
- 48.9%
| Contract | Last | Traded | Volume | Open int. | IV |
|---|---|---|---|---|---|
| 155 call | 2.37 | Nov 12, 12:36 PM | 331 | 1.1K | 54.8% |
| 160 call | 1.19 | Nov 10, 1:44 PM | 15 | 152 | 47.8% |
| 145 put | 2.00 | Nov 12, 2:51 PM | 10 | 55 | 45.2% |
| 130 put | 1.67 | Nov 6, 12:27 PM | 5 | 24 | 78.3% |
| 165 put | 9.86 | Nov 4, 9:40 AM | 5 | 7 | — |
| 130 call | 16.61 | Oct 16, 3:17 PM | 3 | 3 | 59.3% |
Quarterly results
Massive · Nov 4, 2026| Q3 2026 to Sep 30, 2026 | Q2 2026 to Jun 30, 2026 | Q1 2026 to Mar 31, 2026 | Q4 2025 to Dec 31, 2025 | |
|---|---|---|---|---|
| Revenue | $842.00M | $801.70M | $761.70M | $783.80M |
| Gross profit | $632.10M | $562.60M | $529.00M | $568.60M |
| Operating income | $189.80M | $129.70M | $122.10M | $146.30M |
| Net income | $141.10M | $95.00M | $91.10M | $101.60M |
| Diluted EPS | 2.03 | 1.37 | 1.30 | 1.41 |
| Operating cash flow | $123.50M | $88.40M | $113.80M | $183.30M |
| Assets | $3.42B | $3.17B | $2.99B | $3.19B |
| Liabilities | $1.84B | $1.74B | $1.68B | $1.68B |
| Equity | $1.58B | $1.42B | $1.30B | $1.52B |
Technicals
Massive · Nov 12, 2026- 50-day average142.10
- 200-day average173.22
- RSI (14 days)52.4
Short interest
Massive · Oct 30, 2026- Oct 30, 20265.33M shares · 4.3 days to cover
- Oct 15, 20265.63M shares · 3.1 days to cover
- Sep 30, 20265.36M shares · 3.9 days to cover
- Sep 15, 20265.08M shares · 3.1 days to cover
News coverage
No stories about Insulet Corporation right now.